BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8305393)

  • 1. Endometrial hyperplasia and adenocarcinoma during tibolone (Livial) therapy.
    von Dadelszen P; Gillmer MD; Gray MD; McEwan HP; Pyper RJ; Rollason TP; Wright A
    Br J Obstet Gynaecol; 1994 Feb; 101(2):158-61. PubMed ID: 8305393
    [No Abstract]   [Full Text] [Related]  

  • 2. Endometrial adenocarcinoma after prolonged tibolone therapy.
    Nassar AH; Khalil AM; Seoud MA; Usta IM
    Int J Gynaecol Obstet; 2005 Jul; 90(1):78-9. PubMed ID: 15913616
    [No Abstract]   [Full Text] [Related]  

  • 3. Complex endometrial hyperplasia in the context of tibolone administration.
    Kane SC; Quinn MA
    Aust N Z J Obstet Gynaecol; 2009 Jun; 49(3):338-9. PubMed ID: 19566575
    [No Abstract]   [Full Text] [Related]  

  • 4. Carcinoma of the endometrium in patients treated with tibolone.
    Yazigi R; Sahid S; Contreras L; Rodriguez T
    Gynecol Oncol; 2004 May; 93(2):568-70. PubMed ID: 15099984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of testosterone on the development of endometrial tumors in female rats.
    Terada S; Suzuki N; Uchide K; Akasofu K; Nishida E
    Gynecol Obstet Invest; 1993; 36(1):29-33. PubMed ID: 8349175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial polyp and the levonorgestrel intrauterine system--a case report and literature review.
    Sinha A; Nwosu EC
    J Obstet Gynaecol; 2002 Nov; 22(6):695. PubMed ID: 12554277
    [No Abstract]   [Full Text] [Related]  

  • 7. Endometrial effects of tibolone.
    Archer DF; Hendrix S; Gallagher JC; Rymer J; Skouby S; Ferenczy A; den Hollander W; Stathopoulos V; Helmond FA
    J Clin Endocrinol Metab; 2007 Mar; 92(3):911-8. PubMed ID: 17192288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial effects of tibolone in elderly, osteoporotic women.
    Ettinger B; Kenemans P; Johnson SR; Mol-Arts M; Van Os S; Seifert W; Verweij PJ; Cummings SR
    Obstet Gynecol; 2008 Sep; 112(3):653-9. PubMed ID: 18757665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tibolone and risk of endometrial polyps: a prospective, comparative study with hormone therapy.
    Perez-Medina T; Bajo-Arenas J; Haya J; Sanfrutos L; Iniesta S; Bueno B; Castelo-Branco C
    Menopause; 2003; 10(6):534-7. PubMed ID: 14627862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tibolone: cancers of the breast and endometrium.
    Prescrire Int; 2006 Jun; 15(83):107. PubMed ID: 16764100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe atypical endometrial changes and sequential contraceptive use.
    Kaufman RH; Reeves KO; Dougherty CM
    JAMA; 1976 Aug; 236(8):923-6. PubMed ID: 988889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing effects of estrogens on endometrial carcinogenesis initiated by N-methyl-N-nitrosourea in ICR mice.
    Niwa K; Murase T; Furui T; Morishita S; Mori H; Tanaka T; Mori H; Tamaya T
    Jpn J Cancer Res; 1993 Sep; 84(9):951-5. PubMed ID: 8407561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The possible endometrial risk of ovarian stimulation. Apropos of 3 cases].
    Miannay E; Boutemy JJ; Leroy-Billiard M; Gasnault JP; Leroy JL
    J Gynecol Obstet Biol Reprod (Paris); 1994; 23(1):35-8. PubMed ID: 8157888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of sulpiride and ethylene glycol monomethyl ether on endometrial carcinogenicity in Donryu rats.
    Taketa Y; Inoue K; Takahashi M; Sakamoto Y; Watanabe G; Taya K; Yoshida M
    J Appl Toxicol; 2016 Jun; 36(6):769-76. PubMed ID: 26178146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical endometrial hyperplasia: grounds for possible misdiagnosis of endometrial adenocarcinoma.
    Valenzuela P; Sanz JM; Keller J
    Gynecol Obstet Invest; 2003; 56(3):163-7. PubMed ID: 14534372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant and pseudomalignant hyperplasia adenomatosa of the endometrium in postmenopausal women treated with oestrogen.
    Ostergaard E
    Acta Obstet Gynecol Scand Suppl; 1974; 29():97-102. PubMed ID: 4526169
    [No Abstract]   [Full Text] [Related]  

  • 17. Criteria for differential diagnosis of complex hyperplasia or beyond in endometrial cytology.
    Ishii Y; Fujii M
    Acta Cytol; 1997; 41(4):1095-102. PubMed ID: 9250305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oestrogens and endometrial hyperplasia.
    Thom MH; Studd JW
    Br J Hosp Med; 1980 May; 23(5):506, 508-9, 511-3. PubMed ID: 6992895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of estrogens and metabolites on endometrial carcinogenesis in young adult mice initiated with N-ethyl-N'-nitro-N-nitrosoguanidine.
    Takahashi M; Shimomoto T; Miyajima K; Yoshida M; Katashima S; Uematsu F; Maekawa A; Nakae D
    Cancer Lett; 2004 Jul; 211(1):1-9. PubMed ID: 15194211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of progesterone on cell division in chemically induced endometrial hyperplasia and adenocarcinoma in mice.
    Kimura J
    Cancer Res; 1978 Jan; 38(1):78-82. PubMed ID: 618585
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.